Skip to content

Role of Diet in patients with liver cirrhosis with muscle loss

Home based Intensive Nutrition Therapy versus Standard Medical Treatment in patients with Frailty and Sarcopenia in decompensated cirrhosis:An Open Label Randomised Trial - HINT TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019387
Enrollment
80
Registered
2019-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K74- Fibrosis and cirrhosis of liver

Interventions

Intervention1: Nutrition therapy: Home based intensive Nutrition therapy. 6 months. Control Intervention1: Medical Management: Standard Medical Therapy. 6 months.

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A.Age >= 18 years B.Diagnosis of cirrhosis confirmed by clinical, biochemical, compatible radiology, histology C.Presence of frailty and sarcopenia

Exclusion criteria

Exclusion criteria: A.Patients with CTP score more than 10 Obese patient (BMI >25kg/m2) B.Patients with active malignancy, hepatocellular carcinoma and, the end-stage renal disease will be excluded from the study. C.Patients having prior study enrolment or enrolment in another conflicting study will be excluded. D.Patients, who are not willing to participate in the study will be excluded. E.Patients who are participating in other clinical trials within past 3 months. F.Patients who has an active evidence of infection G.Patients who had acute organic brain disease in the past 6 months H.Patients who has severe hemodynamic instability, serious heart disease, severe bradycardia or tachycardia at rest I.Patients having renal failure (creatinine clearance rate J.Patients who are not able to perform the strength exercise; severe cognitive impairment (Mini-Mental State Examination <=17), overt hepatic encephalopathy or patients who had physical disability.

Design outcomes

Primary

MeasureTime frame
A.To see the effect of home-based intensive nutrition therapy on frailty scores as measured by the Clinical frailty scale (CFS), (b) Fried frailty criteria (FFC), (c) Short physical performance battery (SPPB), and Liver Frailty Index (LFI). B.To see the changes in prognostic scores (CTP, MELD).Timepoint: Enrolment- 6 months Follow Up-Weekly for First month Monthly for 6 months

Secondary

MeasureTime frame
Unplanned Hospitalisation and death and need of Liver transplantTimepoint: Improvement in BMI,Mid arm circumference, Mid arm muscle circumference, Skeletal Muscle Index at 3 and 6 month follow up

Countries

India

Contacts

Public ContactSUNIL TANEJA

PGIMER,Chandigarh

drsuniltaneja@hotmail.com9592160444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026